These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31692636)

  • 21. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study.
    Soto Guerrero Y; Hernández Castillo R; Santiago E; Ramírez Yuch N; Jaume Anselmi F; Jové R; Flores R; Lebrón R; Ramírez Rivera J
    Bol Asoc Med P R; 2012; 104(3):10-4. PubMed ID: 23156886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
    Barth RH; DeVincenzo N
    Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes.
    Gomez L; Boegler D; Epiard C; Alin L; Arata-Bardet J; Caspar Y; Debillon T; Stanke-Labesque F; Gautier-Veyret E
    Antimicrob Agents Chemother; 2022 May; 66(5):e0219121. PubMed ID: 35465728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of Vancomycin Dosing Guidance During Transition of Care.
    Ng TM; Heng ST; Oon J; Chan M; Tam VH
    J Clin Pharmacol; 2021 Jun; 61(6):806-809. PubMed ID: 33258161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a Pharmacist-Driven Vancomycin and Aminoglycoside Dosing Service in a Pediatric Hospital.
    Hovey SW; Jacobson JL; Welsh KM; Vu BN
    J Pediatr Pharmacol Ther; 2022; 27(4):340-346. PubMed ID: 35558350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Factors which Influence Mortality in Gram-positive Bacteremia in Hemodialysis Patients.
    Rambaran KA; Alzghari SK; Seifert CF
    Cureus; 2018 Jul; 10(7):e2917. PubMed ID: 30186722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin dosing in patients on intermittent hemodialysis.
    Vandecasteele SJ; De Vriese AS
    Semin Dial; 2011; 24(1):50-5. PubMed ID: 21338394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Body Surface Area for Dosing of Vancomycin.
    Sawrey EL; Subramanian MW; Ramirez KA; Snyder BS; Logston BB; Russell GB
    J Pediatr Pharmacol Ther; 2019; 24(4):296-303. PubMed ID: 31337992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple protocol to improve safety and reduce cost in hemodialysis patients undergoing elective surgery.
    Renew JR; Pai SL
    Middle East J Anaesthesiol; 2014 Jun; 22(5):487-92. PubMed ID: 25137865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.
    Lin H; Yeh DD; Levine AR
    Crit Care; 2016 Jul; 20(1):205. PubMed ID: 27363312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin redistribution: dosing recommendations following high-flux hemodialysis.
    Pollard TA; Lampasona V; Akkerman S; Tom K; Hooks MA; Mullins RE; Maroni BJ
    Kidney Int; 1994 Jan; 45(1):232-7. PubMed ID: 8127014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin.
    Kheir MM; Tan TL; Azboy I; Tan DD; Parvizi J
    Clin Orthop Relat Res; 2017 Jul; 475(7):1767-1774. PubMed ID: 28401341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis.
    van de Vijsel LM; Walker SA; Walker SE; Yamashita S; Simor A; Hladunewich M
    Can J Hosp Pharm; 2010 May; 63(3):196-206. PubMed ID: 22478979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.
    Davis SL; Scheetz MH; Bosso JA; Goff DA; Rybak MJ
    Pharmacotherapy; 2013 Dec; 33(12):1256-63. PubMed ID: 23897602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population Pharmacokinetics of Vancomycin in Patients Receiving Hemodialysis in a Malian and a French Center and Simulation of the Optimal Loading Dose.
    Coulibaly B; Maire P; Guitton J; Pelletier S; Tangara M; Aulagner G; Goutelle S
    Ther Drug Monit; 2023 Oct; 45(5):637-643. PubMed ID: 36750447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.